Skip to main content
Clinical Trials/NCT01226589
NCT01226589CompletedNot Applicable

The Impact of Pharmacist Discharge Medication Reconciliation on Unintentional Medication Discrepancies From Inpatient Discharges at the Alberta Cancer Board Cross Cancer Institute

Alberta Health services1 site in 1 country50 target enrollmentStarted: October 1, 2007Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
MRS Correlation with Treatment Response.

Study Overview

Brief Summary

Adverse drug events can occur commonly due to medication errors during the transition of care in a health care facility. Medication reconciliation is the process of comparing medications and providing an accurate medication list as a resource for prescribers, which is currently only being done upon inpatient admission at the CCI. The purpose of this study is to see if pharmacist medication reconciliation at discharge reduces unintentional medication discrepancies for inpatient discharges.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Cancer inpatients under the care of Dr. Follett or Dr. Candler
  • •Cancer inpatients to be discharged from the CCI
  • •Patients >18 years of age
  • •Patients that are taking >1 medications or herbals total at home.

Exclusion Criteria

  • •Cancer inpatients that are considered radioactive or in "hot rooms" (ie. Selectron patients or patients receiving radiation treatment for thyroid)
  • •Patients that do not remain in hospital >72 hours
  • •Patients without a home phone number or equivalent contact number.
  • •Language barrier (patients unable to speak or understand English).
  • •Patients that are readmitted and already included into the study.

Outcomes

Primary Outcomes

MRS Correlation with Treatment Response.

Time Frame: up to 1 year

The percentage of patients with at least one unintentional medication discrepancy after discharge from the Cross Cancer Institute

Secondary Outcomes

  • Correlation with Tumor Stage(up to 1 year)
  • The frequency of each type of unintentional medication discrepancies.

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials